A combination of two drugs which can block the growth of cancer cells has shown promising results in women with a form of ...

People with intermediate risk, localised prostate cancer can be treated as effectively using fewer and higher doses of ...

A new multimillion-pound research programme, involving scientists from The Institute of Cancer Research, London, is aiming to ...

Professor Amy Berrington explains how she and a team of scientists from around the world took on the challenge of updating a classic text for cancer researchers.

Thousands of men could have their prostate cancer diagnosed at an earlier stage when it is easier and cheaper to treat, ...

Our excellence in working with industry and academia, and in engaging with the wider public has been highlighted in the ...

Professor Clare Isacke aims to identify the processes by which tumour cells recruit non-cancerous cells during metastasis. She has held several senior positions at the ICR, including acting as Interim ...

Dr Chris Jones’ group investigates ways to translate basic molecular pathology findings into improved clinical outcomes for children with cancer. Chris Jones is the Interim Head of Division for ...

Our competitive PhD programme is designed for the next generation of world-leading scientists who want a career in cancer research. Our PhD students benefit from an above average salary and ...

Professor Sebastian Guettler is Deputy Head of the Division of Structural Biology. He studies the precise molecular mechanisms of signalling processes central to cancer stem cell function, with a ...

The Royal Marsden NHS Foundation Trust is a world-leading specialist cancer hospital. The Institute of Cancer Research works in close partnership with The Royal Marsden to take the results of our ...

The Institute of Cancer Research, London, has been driving scientific discoveries on cancer and its treatment for more than 100 years. We are internationally renowned for our work into cancer genetics ...